Extended -
release naltrexone can be given as a long - acting injection that is effective for 30 days, lessening the need for repeat visits to a clinic or daily adherence to an oral medication.
Researchers at the Norwegian Centre for Addiction Research (SERAF) in Oslo are examining sustained -
release naltrexone — a non-addictive opioid antagonist that blocks the effects of opiates in the brain.
Not exact matches
Extended -
release injectable
naltrexone, however, has not been studied as a standalone therapy without psychosocial treatment.
They hypothesized that excess brain dopamine
release in heavy alcohol users who also use nicotine / smoke could make them more treatment - resistant in general, but more sensitized to
naltrexone's dopamine lowering effects — leading to their greater response to treatment with the medication than non-smokers.
There were fewer postincarceration deaths from overdose among recently
released inmates after a program was started to provide medications for addiction treatment (including methadone, buprenorphine or
naltrexone) in a state correctional system.